| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.6M | +26.8% |
| SG&A Expense | $4.6M | +22.9% |
| Operating Income | -$9.2M | -24.8% |
| Income Tax | $0 | — |
| Net Income | -$8.7M | -21.7% |
| EPS (Basic) | -$1.45 | +84.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.0M | +290.8% |
| Current Assets | $21.5M | +274.4% |
| Total Assets | $21.5M | +274.5% |
| Total Liabilities | $1.3M | +32.0% |
| Stockholders' Equity | $20.1M | +326.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.0M | -12.2% |
| Capital Expenditures | $12K | +1100.0% |
| Investing Cash Flow | -$12K | -250.0% |
| Financing Cash Flow | $23.6M | +491.6% |
| Free Cash Flow | -$8.0M | -12.3% |